Chronic Kidney Disease in Cancer Survivors.

As breakthroughs in cancer care are leading to improved long-term outcomes in a subset of advanced cancers, there is a growing population of long-term cancer survivors that are at risk of long-term complications. In this review, we summarize what is known about chronic kidney disease in cancer survivors, focusing on the following high-risk groups: survivors of childhood cancers, stem cell transplant recipients, patients with renal cell carcinoma, patients exposed to cisplatin and other nephrotoxic chemotherapies, and patients receiving immunotherapy for cancer. As new anticancer therapies are developed, more research is needed to understand the long-term risks of kidney function decline and to devise methods to prevent chronic kidney disease. Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Citation

Meghan Lee, Qiyu Wang, Rimda Wanchoo, Meghana Eswarappa, Priya Deshpande, Meghan E Sise. Chronic Kidney Disease in Cancer Survivors. Advances in chronic kidney disease. 2021 Sep;28(5):469-476.e1

Mesh Tags

Substances

PMID: 35190113

search → result